Alpha Emitter Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Global Alpha Emitters Market Report is Segmented by Type of Radionuclide (Astatine [At-211], Radium [Ra-223], Lead [Pb-212], Bismuth [Bi-212], Actinium [Ac-225], and Other Type of Radionuclides), Medical Application (Prostate Cancer, Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Endocrine Tumors, and Other Medical Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across the major regions globally. The market provides the value (in USD million) for all the above segments.

Alpha Emitter Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Alpha Emitter Industry Overview

The alpha emitter market is less competitive and consists of very few major players. Companies like IBA Radiopharma Solutions, Bayer AG, Alpha Tau Medical Ltd, Actinium Pharmaceutical Inc., Telix Pharmaceuticals Ltd, RadioMedix Inc., and Fusion Pharmaceuticals hold a substantial share in the market.

Alpha Emitter Market Leaders

  1. Alpha Tau Medical Ltd

  2. IBA Radiopharma Solutions

  3. Bayer AG

  4. Actinium Pharmaceuticals Inc.

  5. IBA Radiopharma Solutions

  6. RadioMedix Inc.

  7. *Disclaimer: Major Players sorted in no particular order
IBA Radiopharma Solutions, Bayer AG, Alpha Tau Medical Ltd, Actinium Pharmaceutical Inc., Telix Pharmaceuticals Ltd